Top Page
Cohort plc
(LSE:CHRT)
Cohort plc (CHRT) vs. iShares MSCI United Kingdom ETF (EWC)
Cohort plc Business Overview & Revenue Model
Cohort plc Financial Statement Overview
| Breakdown | TTM | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 280.62M | 270.04M | 202.53M | 182.71M | 137.76M | 143.31M |
| Gross Profit | 79.19M | 90.42M | 76.27M | 64.86M | 56.60M | 53.36M |
| EBITDA | 34.40M | 35.57M | 29.25M | 23.07M | 21.79M | 21.36M |
| Net Income | 18.26M | 19.25M | 15.32M | 11.36M | 9.20M | 5.46M |
Balance Sheet | ||||||
| Total Assets | 413.94M | 396.58M | 252.50M | 210.69M | 203.17M | 190.88M |
| Cash, Cash Equivalents and Short-Term Investments | 53.16M | 74.65M | 55.16M | 41.45M | 40.37M | 32.29M |
| Total Debt | 95.13M | 78.88M | 40.51M | 34.98M | 39.52M | 37.38M |
| Total Liabilities | 247.03M | 236.49M | 142.66M | 110.91M | 113.98M | 105.83M |
| Stockholders Equity | 165.48M | 158.61M | 108.67M | 97.02M | 83.97M | 79.31M |
Cash Flow | ||||||
| Free Cash Flow | -27.65M | 38.00M | 16.36M | 11.29M | 17.52M | 14.97M |
| Operating Cash Flow | -10.79M | 51.18M | 23.02M | 16.52M | 19.52M | 16.22M |
| Investing Cash Flow | -89.57M | -93.65M | -6.16M | -6.11M | -2.37M | -2.54M |
| Financing Cash Flow | 69.18M | 46.18M | -16.92M | -10.57M | -8.70M | -1.55M |
Cohort plc Technical Analysis
Cohort plc Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £2.92B | 61.97 | 5.21% | 1.27% | 0.84% | -62.73% | |
71 Outperform | £62.43B | 31.12 | 17.90% | 1.99% | 11.60% | 8.03% | |
69 Neutral | £573.55M | 30.50 | 13.24% | 1.58% | 23.91% | -14.66% | |
68 Neutral | £6.99B | 24.61 | 46.10% | 0.56% | 7.36% | 48.93% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | £1.44B | 29.83 | 14.44% | 1.64% | -2.53% | 22.25% | |
58 Neutral | £2.66B | -13.08 | ― | 2.00% | -4.59% | -256.51% |
Cohort plc Corporate Events
Cohort plc, an AIM-listed defence technology group based in Reading, Berkshire, operates seven specialist businesses in the U.K., Australia, Germany and Portugal. The group focuses on communications, intelligence, sensors and effectors, providing advanced systems such as naval communications, mobile satellite terminals, sonar, surveillance and electronic warfare solutions to defence and related markets.
The company has reported its latest six‑monthly block listing return for its Company Share Option Plan, showing that 133,918 shares were issued or allotted during the period from 25 August 2025 to 24 February 2026. Following these issuances, 1,405,162 securities remain available but unallotted under the scheme, indicating continued use of equity-based incentives while maintaining a substantial reserve for future employee and management share options.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1328.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc has disclosed that its chief executive, Andrew Thomis, and finance director, Simon Walther, have increased their holdings in the company through automatic reinvestment of interim dividend payments. Following these transactions, Thomis and his closely associated persons now hold 186,759 shares, or 0.40% of the company’s issued share capital, while Walther and his associated person hold 150,935 shares, representing 0.32%.
The dividend reinvestments, executed via Global Nominee, Share Incentive Plan and ISA accounts between 17 and 19 February on AIM, signal continued equity alignment of Cohort’s senior management with shareholders. Although the incremental share purchases are relatively small in volume, they modestly strengthen insider ownership and may be viewed by investors as a sign of management’s ongoing commitment to the group’s long-term prospects in the defence technology sector.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1331.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc has granted a restricted share award to its newly appointed Chief Operating Officer, Christopher Axcell, as part of its executive incentive arrangements. Axcell, who joined the group on 6 February 2026, received an award of 4,435 nil-cost ordinary shares under the Cohort Restricted Share Plan.
The shares are scheduled to vest no earlier than 13 February 2029, subject to Axcell’s continued employment with the Cohort group. The transaction, conducted outside a trading venue, was disclosed in line with EU Market Abuse Regulation requirements, underlining the company’s adherence to governance and transparency standards around senior management remuneration.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1249.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc has reported that, as at 31 January 2026, its issued share capital comprised 46,983,433 ordinary shares of 10 pence each, all carrying one vote per share, with no shares held in treasury. This updated total voting rights figure serves as the new reference denominator for investors assessing whether they must disclose holdings or changes in interests under UK transparency rules, providing clarity for shareholders and reinforcing the company’s compliance with market disclosure requirements.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1249.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc has announced that its subsidiary Marlborough Communications Ltd (MCL) has secured new UK defence contracts worth a combined £17.9m, including a £14.0m award from a UK government customer for immediate delivery of uncrewed air systems with two years of in-service support, in partnership with long-term supplier Skydio. MCL has also received a £3.9m order for tactical audio systems from a UK customer, with Cohort chief executive Andrew Thomis saying the wins underline MCL’s strong customer relationships and engineering capability, strengthen the Group’s order book and revenue visibility, and fully underpin consensus revenue forecasts for the 2025/26 financial year.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1249.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc has published its interim report for the six months to 31 October 2025, making the document available to shareholders via post or online through its investor relations website. The release underscores the company’s ongoing disclosure to the market as it integrates its diversified defence technology portfolio, including the recently acquired EM Solutions, and maintains its positioning as a specialist provider of communications, intelligence, sensor and effector systems to defence customers worldwide.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1190.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc has announced that its Chief Executive, Andrew Thomis, and Finance Director, Simon Walther, will deliver a live investor presentation via Equity Development on 14 January 2026, where they will discuss the company’s recent half-year results and outline its corporate strategy. The webinar, which is free and open to both existing and potential shareholders, will include a Q&A session and be recorded for later viewing, underscoring Cohort’s efforts to enhance transparency and engage more directly with investors as it continues to develop its position in the international defence technology market.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1190.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc has confirmed that as at 31 December 2025 its issued share capital comprised 46,950,593 ordinary shares of 10 pence each, with each share carrying one voting right and no shares held in treasury. This updated total voting rights figure provides the basis for shareholders and investors to calculate whether they are required to disclose holdings or changes in their interests under UK market transparency rules, reinforcing regulatory clarity around the company’s capital structure.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1190.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc has announced that its Chief Executive, Andrew Thomis, and Finance Director, Simon Walther, will host a live investor presentation on the Engage Investor platform on 12 January at 2:30pm GMT. During the session, they will discuss the group’s recent half-year results and outline its corporate strategy, with current shareholders and prospective investors invited to attend, follow the company via a personalised investor hub and submit questions before or during the event, underscoring Cohort’s efforts to enhance transparency and engagement with the investment community.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1190.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc announced that its Chief Executive, Andrew Thomis, transferred 80,000 ordinary shares to his spouse without any change in his beneficial interest, which remains at 186,600 shares, representing 0.40% of the company’s total issued share capital. This transaction, conducted on the London Stock Exchange AIM, is part of regulatory compliance and does not impact the company’s operations or market positioning.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1190.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc announced that Simon Walther, the Finance Director, transferred 75,000 ordinary shares to his spouse without any financial consideration, maintaining his beneficial interest in the company at 0.32% of the total issued share capital. This transaction, conducted outside of a Main Market, is in compliance with the EU Market Abuse Regulation, and does not alter the overall shareholding structure, reflecting a neutral impact on the company’s operations and market positioning.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1190.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc reported a 9% increase in revenue to £128.8 million for the first half of 2025, driven by contributions from EM Solutions and other group businesses, except MCL. Despite a slight decrease in adjusted operating profit to £9.7 million, the company maintained a strong order book of £604.5 million and increased its interim dividend by 10%, reflecting confidence in future growth. The Communications and Intelligence division saw a significant profit increase, while the Sensors and Effectors division experienced lower margins due to specific project contributions. The company expects improved performance in the second half of the year, supported by a robust order book and positive outlook for organic growth in core defence markets.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1190.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc, an AIM-listed independent technology group, announced its total voting rights as of November 30, 2025, with an issued share capital of 46,930,296 ordinary shares, each carrying one vote. This update allows shareholders to calculate their interest in the company’s shares under the FCA’s Disclosure Guidance and Transparency Rules, impacting stakeholders’ understanding of their shareholding and potential voting power.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1179.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.
Cohort plc has announced that it will release its half-year results for the six months ending October 31, 2025, on December 10, 2025. This announcement is significant for stakeholders as it provides insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and investor confidence.
The most recent analyst rating on (GB:CHRT) stock is a Hold with a £1179.00 price target. To see the full list of analyst forecasts on Cohort plc stock, see the GB:CHRT Stock Forecast page.